Picture of Regulus Therapeutics logo

RGLS — Regulus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Regulus Therapeutics Reports Third Quarter 2022 Financial Results And Recent Updates

Nov 10 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND RECENT UPDATES
    * REGULUS THERAPEUTICS INC - QTRLY  LOSS PER SHARE $0.50

Source text for Eikon:  ID:nPnbhwZS1a 
Further company coverage:  RGLS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Regulus Therapeutics

See all news